When compared to treatment with chemotherapy alone, 4-year survival for patients treated with ipilimumab was between 13.8 and 28.4%, and a positive trend was seen in survival rates in patients who were given higher doses of ipilimumab [ 31 ].
← all excerpts
Patterns and trends in melanoma mortality in the United States, 1999-2020.
1
—
—